Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Association between oral anticoagulants and COVID-19 related outcomes: two cohort studies

The OpenSAFELY Collaborative, Angel YS Wong, Laurie Tomlinson, Jeremy P Brown, William Elson, Alex J Walker, Anna Schultze, Caroline E Morton, David Evans, Peter Inglesby, View ORCID ProfileBrian MacKenna, Krishnan Bhaskaran, View ORCID ProfileChristopher T Rentsch, Emma Powell, Elizabeth Williamson, Richard Croker, Seb Bacon, William Hulme, Chris Bates, View ORCID ProfileHelen J Curtis, Amir Mehrkar, Jonathan Cockburn, View ORCID ProfileHelen I McDonald, View ORCID ProfileRohini Mathur, Kevin Wing, Harriet Forbes, View ORCID ProfileRosalind M Eggo, Stephen JW Evans, Liam Smeeth, View ORCID ProfileBen Goldacre, Ian J Douglas
doi: https://doi.org/10.1101/2021.04.30.21256119
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
Angel YS Wong
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Angel.Wong@lshtm.ac.uk
Laurie Tomlinson
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy P Brown
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Elson
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alex J Walker
2The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Schultze
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caroline E Morton
2The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Evans
2The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Inglesby
2The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian MacKenna
2The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brian MacKenna
Krishnan Bhaskaran
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher T Rentsch
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher T Rentsch
Emma Powell
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth Williamson
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Croker
2The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seb Bacon
2The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Hulme
2The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Bates
3TPP, TPP House, Horsforth, Leeds
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen J Curtis
2The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Helen J Curtis
Amir Mehrkar
2The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Cockburn
3TPP, TPP House, Horsforth, Leeds
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen I McDonald
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
4NIHR Health Protection Research Unit (HPRU) in Immunisation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Helen I McDonald
Rohini Mathur
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rohini Mathur
Kevin Wing
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harriet Forbes
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosalind M Eggo
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rosalind M Eggo
Stephen JW Evans
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liam Smeeth
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
4NIHR Health Protection Research Unit (HPRU) in Immunisation
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben Goldacre
2The DataLab, Nuffield Department of Primary Care Health Sciences, University of Oxford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ben Goldacre
Ian J Douglas
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives We investigated the role of routinely prescribed oral anticoagulants (OACs) in COVID-19 outcomes, comparing current OAC use versus non-use in Study 1; and warfarin versus direct oral anticoagulants (DOACs) in Study 2.

Design Two cohort studies, on behalf of NHS England.

Setting Primary care data and pseudonymously-linked SARS-CoV-2 antigen testing data, hospital admissions, and death records from England.

Participants Study 1: 70,464 people with atrial fibrillation (AF) and CHA□DS□-VASc score of 2. Study 2: 372,746 people with non-valvular AF.

Main outcome measures Time to test for SARS-CoV-2, testing positive for SARS-CoV-2, COVID-19 related hospital admission, COVID-19 deaths or non-COVID-19 deaths in Cox regression.

Results In Study 1, we included 52,416 current OAC users and 18,048 non-users. We observed no difference in risk of being tested for SARS-CoV-2 associated with current use (adjusted HR, 1.01, 95%CI, 0.96 to 1.05) versus non-use. We observed a lower risk of testing positive for SARS-CoV-2 (adjusted HR, 0.73, 95%CI, 0.60 to 0.90), and COVID-19 deaths (adjusted HR, 0.69, 95%CI, 0.49 to 0.97) associated with current use versus non-use. In Study 2, we included 92,339 warfarin users and 280,407 DOAC users. We observed a lower risk of COVID-19 deaths (adjusted HR, 0.79, 95%CI, 0.76 to 0.83) associated with warfarin versus DOACs. Similar associations were found for all other outcomes.

Conclusions Among people with AF and a CHA□DS□-VASc score of 2, those receiving OACs had a lower risk of receiving a positive COVID-19 test and severe COVID-19 outcomes than non-users; this might be explained by a causal effect of OACs in preventing severe COVID-19 outcomes or more cautious behaviours leading to reduced infection risk. There was no evidence of a higher risk of severe COVID-19 outcomes associated with warfarin versus DOACs in people with non-valvular AF regardless of CHA□DS□-VASc score.

What is already known on this topic

  • Current studies suggest that prophylactic or therapeutic anticoagulant use, particularly low molecular weight heparin, lower the risk of pulmonary embolism and mortality during hospitalisation among patients with COVID-19.

  • Reduced vitamin K status has been reported to be correlated with severity of COVID-19. This could mean that warfarin, as a vitamin K antagonist, is associated with more severe COVID-19 disease than non-vitamin K anticoagulants.

What this study adds

  • In 70,464 people with atrial fibrillation, at the threshold of being treated with an OAC based on risk of stroke, we observed a lower risk of testing positive for SARS-CoV-2 and COVID-19 related deaths associated with routinely prescribed OACs, relative to non-use.

  • This might be explained by OACs preventing severe COVID-19 outcomes, or more cautious behaviours and environmental factors reducing the risk of SARS-CoV-2 infection in those taking OACs.

  • In 372,746 people with non-valvular atrial fibrillation, there was no evidence of a higher risk of severe COVID-19 outcomes associated with warfarin compared with DOACs.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the Medical Research Council MR/V015737/1. TPP provided technical expertise and infrastructure within their data centre pro bono in the context of a national emergency. Work of BG on better use of data in healthcare more broadly is currently funded in part by: NIHR Oxford Biomedical Research Centre, NIHR Applied Research Collaboration Oxford and Thames Valley, the Mohn-Westlake Foundation, NHS England, and the Health Foundation; all DataLab staff are supported by grants of BG on this work. LS reports grants from Wellcome, MRC, NIHR, UKRI, British Council, GSK, British Heart Foundation, and Diabetes UK outside this work. AYSW holds a fellowship from BHF. JPB is funded by a studentship from GSK. AS is employed by LSHTM on a fellowship sponsored by GSK. KB holds a Sir Henry Dale fellowship jointly funded by Wellcome and the Royal Society. HIM is funded by the National Institute for Health Research (NIHR) Health Protection Research Unit in Immunisation, a partnership between Public Health England and LSHTM. RM holds a Sir Henry Wellcome fellowship. EW holds grants from MRC. RG holds grants from NIHR and MRC. ID holds grants from NIHR and GSK. HF holds a UKRI fellowship. The views expressed are those of the authors and not necessarily those of the NIHR, NHS England, Public Health England or the Department of Health and Social Care. Funders had no role in the study design, collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Health Research Authority (REC reference 20/LO/0651) and by the LSHTM Ethics Board (reference 21863).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵† Joint principal investigators

Data Availability

All codelists for identifying exposures, covariates and outcomes are openly shared at https://codelists.opensafely.org/ for inspection and re-use. All study analyses were pre-planned unless otherwise stated. All code for data management and analyses in addition to the pre-specified protocol (https://github.com/opensafely/anticoagulants-research/blob/master/protocol/Protocol_%20Anticoag%20OpenSAFELY_v3.docx) are archived at: https://github.com/opensafely/anticoagulants-research.

  • Abbreviation

    AF
    atrial fibrillation
    CI
    confidence interval
    COVID-19
    coronavirus disease 2019
    DAG
    Directed Acyclic Graph
    DOAC
    direct oral anticoagulants
    HR
    Hazard ratio
    OAC
    oral anticoagulants
    NHS
    National Health Service
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
    Back to top
    PreviousNext
    Posted April 30, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Association between oral anticoagulants and COVID-19 related outcomes: two cohort studies
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Association between oral anticoagulants and COVID-19 related outcomes: two cohort studies
    The OpenSAFELY Collaborative, Angel YS Wong, Laurie Tomlinson, Jeremy P Brown, William Elson, Alex J Walker, Anna Schultze, Caroline E Morton, David Evans, Peter Inglesby, Brian MacKenna, Krishnan Bhaskaran, Christopher T Rentsch, Emma Powell, Elizabeth Williamson, Richard Croker, Seb Bacon, William Hulme, Chris Bates, Helen J Curtis, Amir Mehrkar, Jonathan Cockburn, Helen I McDonald, Rohini Mathur, Kevin Wing, Harriet Forbes, Rosalind M Eggo, Stephen JW Evans, Liam Smeeth, Ben Goldacre, Ian J Douglas
    medRxiv 2021.04.30.21256119; doi: https://doi.org/10.1101/2021.04.30.21256119
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Association between oral anticoagulants and COVID-19 related outcomes: two cohort studies
    The OpenSAFELY Collaborative, Angel YS Wong, Laurie Tomlinson, Jeremy P Brown, William Elson, Alex J Walker, Anna Schultze, Caroline E Morton, David Evans, Peter Inglesby, Brian MacKenna, Krishnan Bhaskaran, Christopher T Rentsch, Emma Powell, Elizabeth Williamson, Richard Croker, Seb Bacon, William Hulme, Chris Bates, Helen J Curtis, Amir Mehrkar, Jonathan Cockburn, Helen I McDonald, Rohini Mathur, Kevin Wing, Harriet Forbes, Rosalind M Eggo, Stephen JW Evans, Liam Smeeth, Ben Goldacre, Ian J Douglas
    medRxiv 2021.04.30.21256119; doi: https://doi.org/10.1101/2021.04.30.21256119

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (238)
    • Allergy and Immunology (520)
    • Anesthesia (124)
    • Cardiovascular Medicine (1417)
    • Dentistry and Oral Medicine (217)
    • Dermatology (158)
    • Emergency Medicine (291)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (582)
    • Epidemiology (10280)
    • Forensic Medicine (6)
    • Gastroenterology (527)
    • Genetic and Genomic Medicine (2622)
    • Geriatric Medicine (254)
    • Health Economics (496)
    • Health Informatics (1728)
    • Health Policy (788)
    • Health Systems and Quality Improvement (671)
    • Hematology (266)
    • HIV/AIDS (564)
    • Infectious Diseases (except HIV/AIDS) (12080)
    • Intensive Care and Critical Care Medicine (647)
    • Medical Education (273)
    • Medical Ethics (83)
    • Nephrology (288)
    • Neurology (2453)
    • Nursing (144)
    • Nutrition (377)
    • Obstetrics and Gynecology (489)
    • Occupational and Environmental Health (566)
    • Oncology (1318)
    • Ophthalmology (400)
    • Orthopedics (145)
    • Otolaryngology (235)
    • Pain Medicine (168)
    • Palliative Medicine (51)
    • Pathology (342)
    • Pediatrics (776)
    • Pharmacology and Therapeutics (329)
    • Primary Care Research (296)
    • Psychiatry and Clinical Psychology (2393)
    • Public and Global Health (4996)
    • Radiology and Imaging (892)
    • Rehabilitation Medicine and Physical Therapy (523)
    • Respiratory Medicine (681)
    • Rheumatology (309)
    • Sexual and Reproductive Health (255)
    • Sports Medicine (244)
    • Surgery (297)
    • Toxicology (45)
    • Transplantation (140)
    • Urology (108)